In vivo treatment of (NZB X NZW)F1 lupus-like nephritis with monoclonal antibody to gamma interferon

The (NZB X NZW)F1 mouse is recognized as an important animal model of the human disease systemic lupus erythematosus (SLE). Groups of NZB/W F1 mice were treated either with IFN-gamma or with PBS. The results demonstrate that IFN-treated animals have accelerated development of fatal immune complex glomerulonephritis relative to age-matched controls. On the other hand, administration of mAbs specific for IFN- gamma to such mice from 4 to 7 mo of age resulted in significant remission. Development of both proteinuria and anti-DNA antibodies were delayed and survival at 11 mo was increased from less than 20% to 95% in treated mice relative to controls (p less than or equal to 0.001). These findings may have therapeutic implications for the treatment of SLE.

[1]  Y. Koide,et al.  Regulation of HLA class II antigen expression: intracellular signaling molecules responsible for the regulation by IFN-gamma and cross-linking of Fc receptors in HL-60 cells. , 1987, Journal of immunology.

[2]  I. Todd,et al.  Organ‐Specific Autoimmunity: A 1986 Overview , 1986, Immunological reviews.

[3]  R. Steinman,et al.  Local and systemic effects of intradermal recombinant interferon-gamma in patients with lepromatous leprosy. , 1986, The New England journal of medicine.

[4]  B. Stollar,et al.  A rapid ELISA for measurement of antibodies to nucleic acid antigens using UV-treated polystyrene microplates. , 1986, Journal of immunological methods.

[5]  H. Schellekens,et al.  The purification and characterization of rat gamma interferon by use of two monoclonal antibodies. , 1986, The Journal of general virology.

[6]  T. Tabira,et al.  Ia expression in chronic relapsing experimental allergic encephalomyelitis induced by long-term cultured T cell lines in mice. , 1986, Laboratory investigation; a journal of technical methods and pathology.

[7]  T. Honjo,et al.  Cloning of cDNA encoding the murine IgG1 induction factor by a novel strategy using SP6 promoter , 1986, Nature.

[8]  G. Trinchieri,et al.  Immune interferon: a pleiotropic lymphokine with multiple effects. , 1985, Immunology today.

[9]  T. Merigan,et al.  Regulation of expression of class II major histocompatibility antigens on human peripheral blood monocytes and Langerhans cells by interferon. , 1984, Human immunology.

[10]  W. Fierz,et al.  Astrocytes present myelin basic protein to encephalitogenic T-cell lines , 1984, Nature.

[11]  M. Feldmann,et al.  ROLE OF ABERRANT HLA-DR EXPRESSION AND ANTIGEN PRESENTATION IN INDUCTION OF ENDOCRINE AUTOIMMUNITY , 1983, The Lancet.

[12]  H. Mcdevitt,et al.  Treatment of (NZB x NZW)F1 disease with anti-I-A monoclonal antibodies , 1983, The Journal of experimental medicine.

[13]  G. Wong,et al.  Interferon-gamma induces enhanced expression of Ia and H-2 antigens on B lymphoid, macrophage, and myeloid cell lines. , 1983, Journal of immunology.

[14]  P. P. Jones,et al.  Induction of Ia and H-2 antigens on a macrophage cell line by immune interferon. , 1983, Journal of immunology.

[15]  T. Merigan,et al.  Treatment of NZB/NZW F1 hybrid mice with Mycobacterium bovis strain BCG or type II interferon preparations accelerates autoimmune disease. , 1981, Arthritis and rheumatism.

[16]  C. Chany,et al.  Adverse effects of interferon treatment on the life span of NZB mice. , 1979, Biomedicine / [publiee pour l'A.A.I.C.I.G.].

[17]  S. Izui,et al.  Increased spontaneous polyclonal activation of B lymphocytes in mice with spontaneous autoimmune disease. , 1978, Journal of immunology.

[18]  A. Steinberg,et al.  B-lymphocyte alloantigens associated with systemic lupus erythematosus. , 1978, The New England journal of medicine.

[19]  A. Billiau,et al.  Interferon treatment of NZB mice: accelerated progression of autoimmune disease , 1978, Infection and immunity.

[20]  D. Adams,et al.  Three genes for lupus nephritis in NZB x NZW mice , 1978, The Journal of experimental medicine.